CMF (therapy)
|
WikiDoc Resources for CMF (therapy) |
|
Articles |
|---|
|
Most recent articles on CMF (therapy) Most cited articles on CMF (therapy) |
|
Media |
|
Powerpoint slides on CMF (therapy) |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on CMF (therapy) at Clinical Trials.gov Trial results on CMF (therapy) Clinical Trials on CMF (therapy) at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on CMF (therapy) NICE Guidance on CMF (therapy)
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on CMF (therapy) Discussion groups on CMF (therapy) Patient Handouts on CMF (therapy) Directions to Hospitals Treating CMF (therapy) Risk calculators and risk factors for CMF (therapy)
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for CMF (therapy) |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Cyclophosphamide Methotrexate Fluorouracil (CMF) is a commonly used regimen of chemotherapy, and is one of the more toxic regimens used. It is named for the three medicines that comprise the therapy: cyclophosphamide, methotrexate, and 5-fluorouracil.
A combination of medicines is used to prevent problems concerning tumor-resistance against one of the single medicines.